DOUYU INTERNATIONAL HOLD-ADR (DOYU) Fundamental Analysis & Valuation

NASDAQ:DOYU • US25985W2044

Current stock price

4.795 USD
+0.26 (+5.85%)
Last:

This DOYU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DOYU Profitability Analysis

1.1 Basic Checks

  • In the past year DOYU has reported negative net income.
  • In multiple years DOYU reported negative net income over the last 5 years.
  • DOYU had negative operating cash flow in 4 of the past 5 years.
DOYU Yearly Net Income VS EBIT VS OCF VS FCFDOYU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • DOYU has a Return On Assets of -6.55%. This is in the lower half of the industry: DOYU underperforms 62.03% of its industry peers.
  • DOYU's Return On Equity of -10.15% is in line compared to the rest of the industry. DOYU outperforms 48.10% of its industry peers.
Industry RankSector Rank
ROA -6.55%
ROE -10.15%
ROIC N/A
ROA(3y)-2.04%
ROA(5y)-1.56%
ROE(3y)-2.64%
ROE(5y)-2.04%
ROIC(3y)N/A
ROIC(5y)N/A
DOYU Yearly ROA, ROE, ROICDOYU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 10.94%, DOYU is doing worse than 86.08% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DOYU has declined.
  • The Profit Margin and Operating Margin are not available for DOYU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.93%
GM growth 5Y-14.32%
DOYU Yearly Profit, Operating, Gross MarginsDOYU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DOYU Health Analysis

2.1 Basic Checks

  • DOYU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DOYU has been reduced compared to 1 year ago.
  • Compared to 5 years ago, DOYU has less shares outstanding
  • There is no outstanding debt for DOYU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DOYU Yearly Shares OutstandingDOYU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DOYU Yearly Total Debt VS Total AssetsDOYU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • DOYU has an Altman-Z score of 0.45. This is a bad value and indicates that DOYU is not financially healthy and even has some risk of bankruptcy.
  • DOYU's Altman-Z score of 0.45 is in line compared to the rest of the industry. DOYU outperforms 44.30% of its industry peers.
  • There is no outstanding debt for DOYU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACCN/A
WACC8.01%
DOYU Yearly LT Debt VS Equity VS FCFDOYU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • DOYU has a Current Ratio of 2.26. This indicates that DOYU is financially healthy and has no problem in meeting its short term obligations.
  • DOYU's Current ratio of 2.26 is amongst the best of the industry. DOYU outperforms 81.01% of its industry peers.
  • A Quick Ratio of 2.26 indicates that DOYU has no problem at all paying its short term obligations.
  • DOYU's Quick ratio of 2.26 is amongst the best of the industry. DOYU outperforms 81.01% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.26
DOYU Yearly Current Assets VS Current LiabilitesDOYU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. DOYU Growth Analysis

3.1 Past

  • DOYU shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.36%.
  • The Revenue has decreased by -8.91% in the past year.
  • The Revenue for DOYU have been decreasing by -10.13% on average. This is quite bad
EPS 1Y (TTM)-9.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.33%
Revenue 1Y (TTM)-8.91%
Revenue growth 3Y-22.47%
Revenue growth 5Y-10.13%
Sales Q2Q%-15.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.71% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -7.58% on average over the next years.
EPS Next Y108.22%
EPS Next 2Y55.19%
EPS Next 3Y36.71%
EPS Next 5YN/A
Revenue Next Year-9.72%
Revenue Next 2Y-9.71%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DOYU Yearly Revenue VS EstimatesDOYU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
DOYU Yearly EPS VS EstimatesDOYU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 -5 10 15

More info and screens

Find the best growth stocksShow best growing peers

4

4. DOYU Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DOYU. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 10.53, the valuation of DOYU can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, DOYU is valued cheaply inside the industry as 89.87% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of DOYU to the average of the S&P500 Index (22.67), we can say DOYU is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.53
DOYU Price Earnings VS Forward Price EarningsDOYU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DOYU Per share dataDOYU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DOYU's earnings are expected to grow with 36.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.19%
EPS Next 3Y36.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DOYU Dividend Analysis

5.1 Amount

  • DOYU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DOYU Fundamentals: All Metrics, Ratios and Statistics

DOUYU INTERNATIONAL HOLD-ADR

NASDAQ:DOYU (3/25/2026, 2:17:59 PM)

4.795

+0.26 (+5.85%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-12
Earnings (Next)05-18
Inst Owners22.28%
Inst Owner Change8.54%
Ins Owners3.86%
Ins Owner ChangeN/A
Market Cap151.69M
Revenue(TTM)4.04B
Net Income(TTM)-203.45M
Analysts47.5
Price Target7.51 (56.62%)
Short Float %0.04%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend9.36
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2167.7%
Min EPS beat(2)241.5%
Max EPS beat(2)4093.9%
EPS beat(4)3
Avg EPS beat(4)1098.94%
Min EPS beat(4)-2.54%
Max EPS beat(4)4093.9%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.45%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)6.46%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)6.46%
Revenue beat(8)4
Avg Revenue beat(8)-4.68%
Revenue beat(12)7
Avg Revenue beat(12)-2.52%
Revenue beat(16)10
Avg Revenue beat(16)-1.64%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.53
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)0.46
Fwd EY9.5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.51
BVpS9.19
TBVpS9.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.55%
ROE -10.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.94%
FCFM N/A
ROA(3y)-2.04%
ROA(5y)-1.56%
ROE(3y)-2.64%
ROE(5y)-2.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.93%
GM growth 5Y-14.32%
F-ScoreN/A
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 2.26
Altman-Z 0.45
F-ScoreN/A
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)21.8%
Cap/Depr(5y)55.54%
Cap/Sales(3y)0.31%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.33%
EPS Next Y108.22%
EPS Next 2Y55.19%
EPS Next 3Y36.71%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.91%
Revenue growth 3Y-22.47%
Revenue growth 5Y-10.13%
Sales Q2Q%-15.43%
Revenue Next Year-9.72%
Revenue Next 2Y-9.71%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y60.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year97.91%
EBIT Next 3Y30.12%
EBIT Next 5YN/A
FCF growth 1Y-293.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-400.87%
OCF growth 3YN/A
OCF growth 5YN/A

DOUYU INTERNATIONAL HOLD-ADR / DOYU Fundamental Analysis FAQ

What is the fundamental rating for DOYU stock?

ChartMill assigns a fundamental rating of 4 / 10 to DOYU.


What is the valuation status for DOYU stock?

ChartMill assigns a valuation rating of 4 / 10 to DOUYU INTERNATIONAL HOLD-ADR (DOYU). This can be considered as Fairly Valued.


How profitable is DOUYU INTERNATIONAL HOLD-ADR (DOYU) stock?

DOUYU INTERNATIONAL HOLD-ADR (DOYU) has a profitability rating of 1 / 10.


Can you provide the financial health for DOYU stock?

The financial health rating of DOUYU INTERNATIONAL HOLD-ADR (DOYU) is 8 / 10.


What is the expected EPS growth for DOUYU INTERNATIONAL HOLD-ADR (DOYU) stock?

The Earnings per Share (EPS) of DOUYU INTERNATIONAL HOLD-ADR (DOYU) is expected to grow by 108.22% in the next year.